BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25089879)

  • 1. Retinal prosthetics, optogenetics, and chemical photoswitches.
    Marc R; Pfeiffer R; Jones B
    ACS Chem Neurosci; 2014 Oct; 5(10):895-901. PubMed ID: 25089879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal stimulation strategies to restore vision: Fundamentals and systems.
    Yue L; Weiland JD; Roska B; Humayun MS
    Prog Retin Eye Res; 2016 Jul; 53():21-47. PubMed ID: 27238218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photochemical approaches to vision restoration.
    Van Gelder RN
    Vision Res; 2015 Jun; 111(Pt B):134-41. PubMed ID: 25680758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optogenetics and prosthetic treatment of retinal degeneration].
    Kirpichnikov MP; Ostrovskiy MA
    Vestn Oftalmol; 2015; 131(3):99-111. PubMed ID: 26310015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsins for vision restoration.
    Simon CJ; Sahel JA; Duebel J; Herlitze S; Dalkara D
    Biochem Biophys Res Commun; 2020 Jun; 527(2):325-330. PubMed ID: 31982136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optogenetic Stimulation for Restoring Vision to Patients Suffering From Retinal Degenerative Diseases: Current Strategies and Future Directions.
    Montazeri L; El Zarif N; Trenholm S; Sawan M
    IEEE Trans Biomed Circuits Syst; 2019 Dec; 13(6):1792-1807. PubMed ID: 31689206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoring Vision to the Blind with Chemical Photoswitches.
    Tochitsky I; Kienzler MA; Isacoff E; Kramer RH
    Chem Rev; 2018 Nov; 118(21):10748-10773. PubMed ID: 29874052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A light in the dark: state of the art and perspectives in optogenetics and optopharmacology for restoring vision.
    Chemi G; Brindisi M; Brogi S; Relitti N; Butini S; Gemma S; Campiani G
    Future Med Chem; 2019 Mar; 11(5):463-487. PubMed ID: 30907134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-Review: Cell Type-Specific Optogenetic Vision Restoration Approaches.
    Chaffiol A; Duebel J
    Adv Exp Med Biol; 2018; 1074():69-73. PubMed ID: 29721929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STEM CELL THERAPIES, GENE-BASED THERAPIES, OPTOGENETICS, AND RETINAL PROSTHETICS: Current State and Implications for the Future.
    Wood EH; Tang PH; De la Huerta I; Korot E; Muscat S; Palanker DA; Williams GA
    Retina; 2019 May; 39(5):820-835. PubMed ID: 30664120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Azobenzene Photoswitches Restore Visual Responses to the Blind Retina.
    Tochitsky I; Helft Z; Meseguer V; Fletcher RB; Vessey KA; Telias M; Denlinger B; Malis J; Fletcher EL; Kramer RH
    Neuron; 2016 Oct; 92(1):100-113. PubMed ID: 27667006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
    Kralik J; Kleinlogel S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies for developing second generation retinal prostheses.
    Benfenati F; Lanzani G
    Lab Anim (NY); 2018 Mar; 47(3):71-75. PubMed ID: 29483694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic Therapy for Visual Restoration.
    Sakai D; Tomita H; Maeda A
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photopharmacological control of bipolar cells restores visual function in blind mice.
    Laprell L; Tochitsky I; Kaur K; Manookin MB; Stein M; Barber DM; Schön C; Michalakis S; Biel M; Kramer RH; Sumser MP; Trauner D; Van Gelder RN
    J Clin Invest; 2017 Jun; 127(7):2598-2611. PubMed ID: 28581442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintaining ocular safety with light exposure, focusing on devices for optogenetic stimulation.
    Yan B; Vakulenko M; Min SH; Hauswirth WW; Nirenberg S
    Vision Res; 2016 Apr; 121():57-71. PubMed ID: 26882975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies for inherited retinal degeneration.
    Scholl HP; Strauss RW; Singh MS; Dalkara D; Roska B; Picaud S; Sahel JA
    Sci Transl Med; 2016 Dec; 8(368):368rv6. PubMed ID: 27928030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The functional characteristics of optogenetic gene therapy for vision restoration.
    Lindner M; Gilhooley MJ; Peirson SN; Hughes S; Hankins MW
    Cell Mol Life Sci; 2021 Feb; 78(4):1597-1613. PubMed ID: 32728765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.